Paper Review Records
全部论文审稿周期
19 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
157
天
Assessing the Risk of Adverse Maternal and Infant Outcomes Following Prenatal Modafinil Exposure: A French Nationwide Cohort Study
作者
Sigal Kaplan; Julie de Nascimento; Andrea Contini展开收起
作者单位
1. Epidemiology, Teva Pharmaceutical Industries Ltd., Netanya, Israel; 2. IQVIA, Real World Data, Paris, France展开收起
8
天
Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence
作者
Mohamed A. Elhawary; Brian Edwards; Hadir Rostom; Shanthi N. Pal; Viola Macolic Sarinic; Priya Bahri; Deirdre McCarthy; Victoria Prudence Nambasa; Linda Härmark; Andrew Bate; Rebecca Chandler; Marco Tuccori; Fawaz Alharbi; Mohammed Fouda; Comfort Ogar; Jürgen Beckmann; Jayesh Pandit; Mayada Alkhakany; Christina Saad; Manal M. Younus; Ivor Ralph Edwards; Omar Aimer展开收起
作者单位
1. Egyptian Ministry of Health and Population (General Secretary of ISoP Egypt Chapter), Cairo, Egypt; 2. Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; 3. International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK; 4. Husoteria Consultancy Ltd, London, UK; 5. International Society of Pharmacovigilance-Egypt Chapter, Cairo, Egypt; 6. Faculty of Pharmacy, MSA University, Giza, Egypt; 7. Regulation and Safety, World Health Organization, Geneva, Switzerland; 8. European Medicines Agency, Amsterdam, The Netherlands; 9. International Society of Pharmacovigilance, Special Interest Group on Medicinal Product Risk Communication, Geneva, Switzerland; 10. Gates Foundation, Seattle, USA; 11. African Union Development Agency-NEPAD, Johannesburg, South Africa; 12. Drug Safety Research Unit, Southampton, UK; 13. Global Safety, GSK, Middlesex, UK; 14. Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; 15. Coalition for Epidemic Preparedness Innovations, Oslo, Norway; 16. Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy; 17. Regional Centre of Pharmacovigilance-Veneto Region, Verona, Italy; 18. Saudi Food and Drug Authority, Riyadh, Saudi Arabia; 19. United States Pharmacopeia, Rockville, USA; 20. Berlin, Germany; 21. International Society of Pharmacovigilance Africa Chapter, Nairobi, Kenya; 22. Bayer Healthcare, Nairobi, Kenya; 23. International Society of Pharmacovigilance Patient Engagement Special Interest Group, London, UK; 24. Seven D Consultancy, Dubai, UAE; 25. Bayer Pharmaceuticals Inc., Cairo, Egypt; 26. International Society of Pharmacovigilance Middle East Chapter, Baghdad, Iraq; 27. Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq; 28. Gothenburg, Sweden; 29. InnoVigilance, Laval, Canada展开收起
70
天
Incidence of Naloxone-Use Before and After Implementing Opioid Safety Measures for Patients Hospitalised on General Wards in a Swiss University Hospital
作者
Anja Jungo; Kanchan Dongre; Delia Halbeisen; Tobias Schneider; Sibylle Chettata; Niklaus Gygli; Murat Bilici; Christoph R. Meier; Anne B. Leuppi-Taegtmeyer展开收起
作者单位
1. Department of Pharmaceutical Science, University of Basel, Basel, Switzerland; 2. Department of Patient Safety, Medical Directorate, University Hospital Basel, Basel, Switzerland; 3. Department of Clinical Research, University of Basel, Basel, Switzerland; 4. Hospital Pharmacy, University Hospital Basel, Basel, Switzerland; 5. Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland; 6. Department of Nursing, Medical Directorate, University Hospital Basel, Basel, Switzerland; 7. Department of Quality Management, Medical Directorate, University Hospital Basel, Basel, Switzerland展开收起
111
天
Assessing Natural Health Product-Drug Interactions and Coding Feasibility: Analysis of a New Zealand General Population Dataset from an Online Market Research Panel
作者
E Lyn Lee; Fraser Ogle; Jyadeep Nagra; Sofia Su Ye; Jeff Harrison; Joanne Barnes展开收起
作者单位
1. School of Pharmacy, University of Auckland, Auckland, New Zealand展开收起
127
天
Educational Interventions Affecting Medication Error Reporting by Healthcare Professionals in Secondary and Tertiary Care: A Systematic Review and Narrative Synthesis
作者
Manahil M. Monshi; Zahraa Jalal; Jeff Aston; Sarah K. Pontefract; Anthony R. Cox展开收起
作者单位
1. Department of Pharmacy, School of Health Sciences, University of Birmingham, Birmingham, UK; 2. Yanbu General Hospital, Yanbu, Madina Health Cluster, Al Madinah Al Munawwarah, Saudi Arabia; 3. Pharmacy Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK展开收起
141
天
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool
作者
Yanning Wang; Celeste L. Y. Ewig; Nicole E. Smolinski; Gita A. Toyserkani; Cynthia LaCivita; Esther H. Zhou; Gerald J. Dal Pan; Thuy Nhu Thai; Judith C. Maro; Sonja A. Rasmussen; Almut G. Winterstein展开收起
作者单位
1. Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, USA; 2. Center for Drug Evaluation and Safety, University of Florida, Gainesville, USA; 3. Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, USA; 4. Independent, Potomac, USA; 5. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, USA; 6. Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, USA; 7. Department of Epidemiology, University of Florida, Gainesville, USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天